Hedge Fund - DAFNA Capital Management
Fate Therapeutics Inc (FATE)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $6.03 |
| 2 | 2022 - Q4 (2022-12-31) | $5,558,985 | 1.56% | 550,940 | $18.78 |
| 3 | 2022 - Q3 (2022-09-30) | $12,100,000 | 3.25% | 539,940 | $28.89 |
| 4 | 2022 - Q2 (2022-06-30) | $13,652,000 | 3.72% | 550,940 | $27.59 |
| 5 | 2022 - Q1 (2022-03-31) | $19,421,000 | 5.06% | 500,930 | $38.72 |
| 6 | 2021 - Q4 (2021-12-31) | $21,775,000 | 5.47% | 372,160 | $56.68 |
| 7 | 2021 - Q3 (2021-09-30) | $20,410,000 | 5.41% | 344,360 | $78.44 |
| 8 | 2021 - Q2 (2021-06-30) | $27,283,000 | 5.7% | 314,360 | $80.58 |
| 9 | 2021 - Q1 (2021-03-31) | $25,919,000 | 6.14% | 314,360 | $95.82 |
| 10 | 2020 - Q4 (2020-12-31) | $30,403,000 | 9.04% | 334,360 | $62.10 |
| 11 | 2020 - Q3 (2020-09-30) | $17,525,000 | 5.69% | 438,460 | $34.92 |
| 12 | 2020 - Q2 (2020-06-30) | $16,841,000 | 4.86% | 490,861 | $29.80 |
| 13 | 2020 - Q1 (2020-03-31) | $10,439,000 | 4.35% | 470,000 | $25.29 |
| 14 | 2019 - Q4 (2019-12-31) | $9,198,000 | 3.15% | 470,000 | $15.88 |
| 15 | 2019 - Q3 (2019-09-30) | $7,299,000 | 2.74% | 470,000 | $19.17 |
| 16 | 2019 - Q2 (2019-06-30) | $1,219,000 | 0.45% | 60,031 | $18.02 |
| 17 | 2015 - Q2 (2015-06-30) | $0 | 0% | 0 | $5.98 |
| 18 | 2015 - Q1 (2015-03-31) | $99,000 | 0.07% | 20,190 | $4.96 |
| 19 | 2014 - Q4 (2014-12-31) | $297,000 | 0.23% | 59,110 | $4.41 |
| 20 | 2014 - Q3 (2014-09-30) | $387,000 | 0.39% | 75,930 | $5.78 |
| 21 | 2014 - Q2 (2014-06-30) | $479,000 | 0.45% | 75,930 | $7.04 |
The displayed share prices are average quarterly stock market prices.